CDK1 and metabolic dysfunction-associated steatohepatitis: Over time, chronic hyperinsulinemia culminates in the development of liver disease and a diabetes-like phenotype, as observed in aged Cdk1 cKO liver by the presence of insulin resistance and a NASH-like phenotype that is potentially on course to oncogenesis (Xu et al., 2017).